What is the appropriate dosage of Co-amoxiclav (amoxicillin/clavulanic acid) 250mg/65mg per 7.5mL for a 41kg, 8-12 year old child?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 11, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Co-Amoxiclav Dosing for a 41kg Child

For a 41kg child aged 8-12 years, the appropriate dose is 10 mL of the 250mg/62mg suspension three times daily, providing approximately 333mg of amoxicillin per dose (total 1000mg/day or 24mg/kg/day), which is the standard-dose regimen for this age group. 1

Age-Based Dosing Algorithm

The dosing of co-amoxiclav in children follows an age-based rather than strict weight-based algorithm for standard infections 1:

  • Children 7-12 years: 5 mL of 250/62 suspension three times daily 1, 2
  • This provides approximately 250mg amoxicillin per dose, totaling 750mg daily 1

However, for a 41kg child (which is above average weight for this age range), doubling the volume to 10 mL three times daily is appropriate to achieve adequate dosing, providing approximately 1000mg amoxicillin daily (24mg/kg/day) 1.

When High-Dose Therapy Is Required

High-dose co-amoxiclav (90 mg/kg/day of amoxicillin component in 2 divided doses) is indicated if the child has any of these risk factors 1, 2:

  • Age <2 years
  • Daycare attendance 1
  • Recent antibiotic use within the previous 30 days 1
  • Incomplete Haemophilus influenzae type b vaccination 1
  • Geographic area with high prevalence (>10%) of penicillin-resistant S. pneumoniae 1
  • Moderate to severe illness 1
  • Treatment failure with standard-dose amoxicillin 3, 4

For this 41kg child requiring high-dose therapy, the dose would be 3690mg daily (90 mg/kg/day) divided into 2 doses of 1845mg each 1, 2.

Critical Dosing Considerations

Verify the Suspension Concentration

Always verify whether you have 125/31 or 250/62 suspension before calculating volume 1. The 250/62 formulation is specifically indicated for children over 6 years 1.

Treatment Duration

  • Standard respiratory infections: 7-10 days 2
  • Acute otitis media: 10 days 1
  • Acute bacterial rhinosinusitis: 10-14 days 1, 2
  • Community-acquired pneumonia: 10 days 1

Clinical Response Monitoring

Evaluate clinical response within 48-72 hours 1, 2. If no improvement or worsening occurs after 72 hours, reassess the diagnosis and consider atypical pathogens, complications, or alternative diagnoses 1.

Common Pitfalls to Avoid

Underdosing is the most critical error 1. Using subtherapeutic doses fails to achieve adequate serum and tissue concentrations, promotes antimicrobial resistance, and leads to treatment failure with resistant organisms 1. The difference in adverse effects between standard and high-dose regimens is generally negligible, while the clinical benefit of adequate dosing is substantial 1.

The 14:1 ratio formulation (90/6.4 mg/kg/day) causes less diarrhea than other amoxicillin-clavulanate preparations while maintaining efficacy 1, 3, 4.

Severe Infections Requiring IV Therapy

For severe infections requiring intravenous therapy, the dose is 30 mg/kg three times daily IV, which for a 41kg child would be 1230mg IV every 8 hours 1, 2. Dose frequency can be increased to four times daily in severe infections 2.

Renal Insufficiency Adjustment

In patients with renal insufficiency, prolong the dosing interval according to creatinine clearance to avoid accumulation, as both amoxicillin and clavulanic acid are renally eliminated 1.

References

Guideline

Amoxicillin-Clavulanate Dosing in Pediatric Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Amoxicillin-Clavulanate Dosage and Administration

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.